112 related articles for article (PubMed ID: 8735587)
1. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment.
Mizejewski GJ; Dias JA; Hauer CR; Henrikson KP; Gierthy J
Mol Cell Endocrinol; 1996 Apr; 118(1-2):15-23. PubMed ID: 8735587
[TBL] [Abstract][Full Text] [Related]
2. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Vakharia D; Mizejewski GJ
Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
4. A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
Bennett JA; Mesfin FB; Andersen TT; Gierthy JF; Jacobson HI
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2211-5. PubMed ID: 11830647
[TBL] [Abstract][Full Text] [Related]
5. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
6. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
[TBL] [Abstract][Full Text] [Related]
7. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
Mizejewski G; Smith G; Butterstein G
Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
9. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens.
Mizejewski GJ; Vonnegut M; Jacobson HI
Proc Natl Acad Sci U S A; 1983 May; 80(9):2733-7. PubMed ID: 6189129
[TBL] [Abstract][Full Text] [Related]
10. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid.
Mizejewski GJ; Keenan JF; Setty RP
Biol Reprod; 1990; 42(5-6):887-98. PubMed ID: 1696509
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein: the major high-affinity estrogen binder in rat uterine cytosols.
Uriel J; Bouillon D; Aussel C; Dupiers M
Proc Natl Acad Sci U S A; 1976 May; 73(5):1452-6. PubMed ID: 58416
[TBL] [Abstract][Full Text] [Related]
14. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
Mizejewski GJ
Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
[TBL] [Abstract][Full Text] [Related]
15. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Mesfin FB; Andersen TT; Jacobson HI; Zhu S; Bennett JA
J Pept Res; 2001 Sep; 58(3):246-56. PubMed ID: 11576331
[TBL] [Abstract][Full Text] [Related]
16. Mixed estrogenic and anti-estrogenic activities of yuehchukene--a bis-indole alkaloid.
Ng PC; Ho DD; Ng KH; Kong YC; Cheng KF; Stone G
Eur J Pharmacol; 1994 Oct; 264(1):1-12. PubMed ID: 7828637
[TBL] [Abstract][Full Text] [Related]
17. T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.
Butterfield LH; Meng WS; Koh A; Vollmer CM; Ribas A; Dissette VB; Faull K; Glaspy JA; McBride WH; Economou JS
J Immunol; 2001 Apr; 166(8):5300-8. PubMed ID: 11290817
[TBL] [Abstract][Full Text] [Related]
18. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
20. Effect of alpha-fetoprotein and derived peptides on insulin- and estrogen-induced fetotoxicity.
Butterstein G; Morrison J; Mizejewski GJ
Fetal Diagn Ther; 2003; 18(5):360-9. PubMed ID: 12913349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]